Skip to search.
 FTSE 100 Up 0.41%

VIVUS Inc. (VVUS)

-NasdaqGS
1.11 Down 0.01(0.89%) 27 Aug 21:00
Add to Portfolio
Prev Close:1.12
Open:1.13
Bid:1.00 x 1200
Ask:1.18 x 900
1y Target Est:3.15
Beta:1.36345
Earnings Date:3 Nov - 9 Nov (Est.)
Day's Range:1.10 - 1.15
52wk Range:0.94 - 4.82
Volume:776,541
Avg Vol (3m):1,288,180
Market Cap:115.46m
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for VVUS at this time.

Comparison

Symbol% ChgMkt Cap
VVUSDown 0.89%115.46m
GSKUp 1.83%99.60b
LLYUp 3.26%88.68b
PFEUp 2.56%205.13b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.94
Quarterly EPS Est (Sep-15) :-0.17
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback